GABA Market in India, Industry Outlook and Forecast 2024-2030

GABA (γ-aminobutyric acid) is a four carbon non-protein amino acid that is widely distributed in plants, animals and microorganisms. As a metabolic product of plants and microorganisms produced by the decarboxylation of glutamic acid, GABA functions as an inhibitory neurotransmitter in the brain that directly affects the personality and the stress management. A wide range of traditional foods produced by microbial fermentation contain GABA, in which GABA is safe and eco-friendly, and also has the possibility of providing new health-benefited products enriched with GABA. Synthesis of GABA is catalyzed by glutamate decarboxylase, therefore, the optimal fermentation condition is mainly based on the biochemical properties of the enzyme. Major GABA producing microorganisms are lactic acid bacteria (LAB), which make food spoilage pathogens unable to grow and act as probiotics in the gastrointestinal tract.

This report contains market size and forecasts of GABA in India, highlights the following information:

Sales of GABA in India: Value 2019 VS 2023 VS 2030, ($ millions)

Sales of GABA in India: Volume 2019 VS 2023 VS 2030, (MT)

Sales of GABA in India: Revenue Market Share by Company, 2019-2024

Sales of GABA in India: Volume Market Share by Company, 2019-2024

India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.

India is a market full of opportunities, and the demand for GABA will continue to grow rapidly in the future.

The global GABA market size was valued at 81 million in 2023 and is forecast to a readjusted size of US$ 124 million by 2030, with a CAGR of 6.2% during the forecast period 2024-2030.While the India GABA market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. India will account for % percent of GABA's global value in 2030, from % in 2023.

Our research team has surveyed the GABA manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, Value, demand, price change, product matrix, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

India GABA Market, By Type, 2019-2024, 2025-2030 ($ Millions) & (MT)

India GABA Market Segment Percentages, By Type, 2023 (%)

Microbial Fermentation (Feed Grade)

Microbial Fermentation (Food Grade)

Chemical Synthesis

India GABA Market, By Application, 2019-2024, 2025-2030 ($ Millions) & (MT)

India GABA Market Segment Percentages, By Application, 2023 (%)

Animal Feed

Food

Medicine

Plant Growth Promoter

Cosmetic

Other

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies GABA revenues in India market, 2019-2024 (Estimated), ($ millions)

Key companies GABA sales in India market, 2019-2024 (Estimated), (MT)

Further, the report presents profiles of competitors in the market, key players include:

Pharma Foods International

Kyowa Hakko

Sekisui Chemical

Sino Biotek

Zhejiang Yiwan Bio

Shanghai Richen

Luckerkong

Qandr Biology

Bloomage Biotech

Jyswkj

Zjtr Chemistry

Xinyou Chemistry

Bornsun Biology

Huarui Biology

Viab Life

Microbiofeed

Harworld